amylase 15,125 UNT / lipase 4000 UNT / protease 14,375 UNT Delayed Release Oral Capsule

RxCUI
1543004
RxNorm name
amylase 15,125 UNT / lipase 4000 UNT / protease 14,375 UNT Delayed Release Oral Capsule
Display name
amylase 15,125 UNT / lipase 4000 UNT / protease 14,375 UNT Delayed Release Oral Capsule
Full name
amylase 15,125 UNT / lipase 4000 UNT / protease 14,375 UNT Delayed Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
022175Pertzyepancrelipase351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PERTZYEPANCRELIPASEDigestive Care, Inc.481eec00-9abf-11dd-b71c-0002a5d5c51b2024-03-11Warnings, Adverse reactionsExact identifier
rxcui: 1543004

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
481eec00-9abf-11dd-b71c-0002a5d5c51blipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule [PSN] · amylase 15125 UNT / lipase 4000 UNT / protease 14375 UNT Delayed Release Oral Capsule [SCD] · amylase 15,125 UNT / lipase 4000 UNT / protease 14,375 UNT Delayed Release Oral Capsule [SY] · amylases 15,125 UNT / endopeptidases 14,375 UNT / lipase 4000 UNT Delayed Release Oral Capsule [SY]422These highlights do not include all the information needed to use PERTZYE safely and effectively. See full prescribing information for PERTZYE. PERTZYE (pancrelipase) delayed-release capsules, for oral use Initial U.S. Approval: 201220240311